REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
MURELIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MURELIX
ST13
US500000079287792Class
5, 42, 44
Filing
79287792
Registration
6405718
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/06/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
02/07/2020
Registration date
07/06/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
SE
Examiner
SAITO, KIM
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ISR Immune System Regulation Holding AB
Representatives
Jennifer Sheehan Anderson Bridge Intellectual Property Services PL
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspharmaceutical preparations for the treatment and prevention of viral and infectious diseases and pharmaceutical preparations for the treatment of immune dysfunction and pharmaceutical preparations for the treatment of human immunedeficiency virus
Class 42
Scientific research in the medicalpharmaceutical and bacteriological fields; consultancy and information in the field of scientific research as it relates to the medicalpharmaceutical and bacteriological fields; packaging designdesigning and development of medical equipmentdesigning pharmaceutical and medical preparationspreparation of reports relating to pharmaceutical formulation studiesdesign and development of granulation technology and pharmaceutical table technology; consultancy and information in the field of granulation technology and pharmaceutical table technology
Class 44
Information and advice provided on-line via computer networks or the Internet relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparationsdiseases and medical conditions and treatmentproviding information relating to preventiondiagnosis and treatment of infectious diseasesinformation and advice relating to diagnosis and treatment of diseases and medical disorders
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/18/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2021
FIMP
FINAL DISPOSITION PROCESSED
11/02/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/18/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/31/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/31/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/17/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/17/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/17/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2021
RFNT
REFUSAL PROCESSED BY IB
09/12/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/21/2020
RFRR
REFUSAL PROCESSED BY MPU
08/21/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/15/2020
CNRT
NON-FINAL ACTION WRITTEN
07/14/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/23/2020
DOCK
ASSIGNED TO EXAMINER
06/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/18/2020
Continuous trademark protection
Get notified about every new filing that threatens MURELIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.